Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Yogen Saunthararajah, MD
Professor of Medicine
Cleveland Clinic Main Campus
9500 Euclid Avenue
Cleveland, Ohio, United States
Yogen Saunthararajah, MD, is a staff in the department of Hematologic Oncology and Blood Disorders at Cleveland Clinic, a professor of medicine, and co-leader of the developmental therapeutics program of the Case Comprehensive Cancer Center.
His clinical and research interests include acute myeloid leukemia, myelodysplastic syndrome, sickle cell disease/anemia, thalassemia, leukemia, benign hematology, myelodysplasia, cancer, leukopenia, aplastic anemia.
Dr. Yogen developed an Epigenetic Platform that has the potential to identify and eliminate the “road blocks” that prevent cancer cells from becoming specialized, non-dividing cells. According to him, the methodology can be applied to some of the most common and most debilitating genetic disorders in the world, including sickle cell disease and beta thalassemia.
Lillian E.C. McMahon, MDLillian E.C. McMahon, MD is an Associate...
University of Pittsburgh School of MedicineThe University of Pittsburgh School of M...
Martin H. Steinberg, MDDr. Steinberg is currently working as pr...
James R. Clark Memorial Sickle Cell FoundationThe James R. Clark Memorial Sickle Cell ...
The Affordable Care Act Improves Healthcare Access and Utilization Among Young Adults with Sickle Cell DiseaseIntroduction: The Dependent Coverage Pro...
Pfizer rare disease introduces Council for Change to further help SCD patientsFollowing a report earlier thi...
2019 NHLBI Annual Sickle Cell Disease Research MeetingThe 2019 NHLBI Annual Sickle Cell Diseas...